Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288907 · ClinicalTrials.gov registry record
SOOTHER Trial to Treat Rectal Itch
A clinical trial of Pruritus Ani, sponsored by Bell International Laboratories.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05288907 is a study of Pruritus Ani that has completed, run by Bell International Laboratories. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05288907, a study of Pruritus Ani, has completed, sponsored by Bell International Laboratories.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Longitudinal, observational, single-arm trial of a novel, composite Lidocaine ointment to treat rectal itch (pruritus ani)
Conditions Studied
Interventions
- DRUG Lidocaine Ointment
Study Locations (1)
Minnesota
- Minnesota Gastroenterology - Plymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2021-12-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05288907
The ClinicalTrials.gov registry entry for NCT05288907 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bell International Laboratories, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pruritus Ani appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine Ointment is the first listed.
NCT05288907 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05288907 about?
NCT05288907 is a clinical study titled "SOOTHER Trial to Treat Rectal Itch". Longitudinal, observational, single-arm trial of a novel, composite Lidocaine ointment to treat rectal itch (pruritus ani)
What is the current status of trial NCT05288907?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-09-01. Estimated completion is 2021-12-10.
What conditions does trial NCT05288907 study?
This clinical trial studies the following conditions: Pruritus Ani.
What interventions are being tested in trial NCT05288907?
The interventions under investigation include: Lidocaine Ointment (DRUG).
Who is sponsoring clinical trial NCT05288907?
This trial is sponsored by Bell International Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288907 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.